Neurological disorders and treatments
Neurological disorders and treatments is a research topic within Neurology. Science Explorer counts 48k research works in it since 1950. 20.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the use of deep brain stimulation (DBS) for neurological disorders such as Parkinson's disease, treatment-resistant depression, epilepsy, and dystonia. The research explores the effects of DBS on the subthalamic nucleus, basal ganglia circuitry, and the treatment outcomes for various neurological conditions.
- Deep Brain Stimulation
- Parkinson's Disease
- Subthalamic Nucleus
- Basal Ganglia
- Treatment-Resistant Depression
- Neuromodulation
- Epilepsy
- Dystonia
- Circuitry
- Neurological Disorders
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 9.8k per year above
- Top-10% rate
- 20.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +16% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Neurological disorders and treatments research?
By volume, the United States and China publish the most (2.2k and 1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.2k works
- 2 China 1k works
- 3 Germany 494 works
- 4 India 488 works
- 5 Italy 456 works
- 6 United Kingdom 421 works
- 7 Canada 309 works
- 8 Japan 306 works
- 9 France 283 works
- 10 Spain 232 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Neurological disorders and treatments research?
By volume in 2022–2025, Capital Medical University publishes the most Neurological disorders and treatments research, followed by University of Florida and University College London.
By volume, 2022–2025
- 1 Capital Medical UniversityChina 46 works
- 2 University of FloridaUnited States 39 works
- 3 University College LondonUnited Kingdom 38 works
- 4 University of TorontoCanada 38 works
- 5 Harvard UniversityUnited States 37 works
- 6 Neurological SurgeryUnited States 37 works
- 7 Emory UniversityUnited States 34 works
- 8 National Institute of Mental Health and NeurosciencesIndia 29 works
- 9 Baylor College of MedicineUnited States 28 works
- 10 Yale UniversityUnited States 27 works
Who are the leading researchers in Neurological disorders and treatments?
The most-cited researchers publishing on Neurological disorders and treatments include Susan E. Folstein, Dan J. Stein and Perminder S. Sachdev.
- 1 Susan E. Folstein United States 10k citations
- 2 Dan J. Stein South Africa 7.7k citations
- 3 Perminder S. Sachdev Australia 4.6k citations
- 4 Seyed‐Mohammad Fereshtehnejad Sweden 4.2k citations
- 5 John Hardy United Kingdom 4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Neurological disorders and treatments research done?
The largest centres of Neurological disorders and treatments research in 2022–2025 are Beijing (China), London (United Kingdom), Toronto (Canada) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Rockville Centre and Wurzburg.
Largest cities, 2022–2025
Where it is the local speciality
- Rockville CentreUS · 36.6 works31×
- WurzburgDE · 22.5 works7.3×
Location quotient: how much more of its research is in Neurological disorders and treatments than the world average.
Where is the best place to study Neurological disorders and treatments?
Among universities, judged by research, Capital Medical University, Baylor College of Medicine and University College London score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Capital Medical UniversityChina | 69.5 | 22.3% | 9.9× | 46 | +60.3% |
| 2 | Baylor College of MedicineUnited States | 60.5 | 26.4% | 8.6× | 28 | -9.8% |
| 3 | University College LondonUnited Kingdom | 59.9 | 29.4% | 3.5× | 38 | +9.7% |
| 4 | Harvard UniversityUnited States | 59.5 | 28.4% | 3.7× | 37 | +36.6% |
| 5 | Innsbruck Medical UniversityAustria | 58.8 | 28.9% | 14.1× | 10 | -20.9% |
| 6 | University of FloridaUnited States | 57.3 | 27.6% | 4.6× | 39 | +20.2% |
| 7 | University of California, San FranciscoUnited States | 56.5 | 28.9% | 5.2× | 26 | +26.1% |
| 8 | Stanford UniversityUnited States | 56.4 | 30.9% | 2.4× | 24 | +127.5% |
| 9 | Karolinska InstitutetSweden | 55.8 | 33.5% | 3.5× | 13 | +47.6% |
| 10 | Magna Graecia UniversityItaly | 55.3 | 23.9% | 12.2× | 10 | +70.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Neurological disorders and treatments research growing?
Output in 2018–2022 was 16% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Neurological disorders and treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.